These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33995346)

  • 1. A Pathogenic Missense Variant in
    Fliegauf M; Krüger R; Steiner S; Hanitsch LG; Büchel S; Wahn V; von Bernuth H; Grimbacher B
    Front Immunol; 2021; 12():621503. PubMed ID: 33995346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental
    Fliegauf M; Kinnunen M; Posadas-Cantera S; Camacho-Ordonez N; Abolhassani H; Alsina L; Atschekzei F; Bogaert DJ; Burns SO; Church JA; Dückers G; Freeman AF; Hammarström L; Hanitsch LG; Kerre T; Kobbe R; Sharapova SO; Siepermann K; Speckmann C; Steiner S; Verma N; Walter JE; Westermann-Clark E; Goldacker S; Warnatz K; Varjosalo M; Grimbacher B
    Front Immunol; 2022; 13():965326. PubMed ID: 36105815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in
    Anim M; Sogkas G; Schmidt G; Dubrowinskaja N; Witte T; Schmidt RE; Atschekzei F
    Front Immunol; 2021; 12():767188. PubMed ID: 35003082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
    Fliegauf M; Bryant VL; Frede N; Slade C; Woon ST; Lehnert K; Winzer S; Bulashevska A; Scerri T; Leung E; Jordan A; Keller B; de Vries E; Cao H; Yang F; Schäffer AA; Warnatz K; Browett P; Douglass J; Ameratunga RV; van der Meer JW; Grimbacher B
    Am J Hum Genet; 2015 Sep; 97(3):389-403. PubMed ID: 26279205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
    Li J; Lei WT; Zhang P; Rapaport F; Seeleuthner Y; Lyu B; Asano T; Rosain J; Hammadi B; Zhang Y; Pelham SJ; Spaan AN; Migaud M; Hum D; Bigio B; Chrabieh M; Béziat V; Bustamante J; Zhang SY; Jouanguy E; Boisson-Dupuis S; El Baghdadi J; Aimanianda V; Thoma K; Fliegauf M; Grimbacher B; Korganow AS; Saunders C; Rao VK; Uzel G; Freeman AF; Holland SM; Su HC; Cunningham-Rundles C; Fieschi C; Abel L; Puel A; Cobat A; Casanova JL; Zhang Q; Boisson B
    J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34473196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
    Kaustio M; Haapaniemi E; Göös H; Hautala T; Park G; Syrjänen J; Einarsdottir E; Sahu B; Kilpinen S; Rounioja S; Fogarty CL; Glumoff V; Kulmala P; Katayama S; Tamene F; Trotta L; Morgunova E; Krjutškov K; Nurmi K; Eklund K; Lagerstedt A; Helminen M; Martelius T; Mustjoki S; Taipale J; Saarela J; Kere J; Varjosalo M; Seppänen M
    J Allergy Clin Immunol; 2017 Sep; 140(3):782-796. PubMed ID: 28115215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
    Tuijnenburg P; Lango Allen H; Burns SO; Greene D; Jansen MH; Staples E; Stephens J; Carss KJ; Biasci D; Baxendale H; Thomas M; Chandra A; Kiani-Alikhan S; Longhurst HJ; Seneviratne SL; Oksenhendler E; Simeoni I; de Bree GJ; Tool ATJ; van Leeuwen EMM; Ebberink EHTM; Meijer AB; Tuna S; Whitehorn D; Brown M; Turro E; Thrasher AJ; Smith KGC; Thaventhiran JE; Kuijpers TW;
    J Allergy Clin Immunol; 2018 Oct; 142(4):1285-1296. PubMed ID: 29477724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous
    Staels F; De Keukeleere K; Kinnunen M; Keskitalo S; Lorenzetti F; Vanmeert M; Prezzemolo T; Pasciuto E; Lescrinier E; Bossuyt X; Gerbaux M; Willemsen M; Neumann J; Van Loo S; Corveleyn A; Willekens K; Stalmans I; Meyts I; Liston A; Humblet-Baron S; Seppänen M; Varjosalo M; Schrijvers R
    Front Immunol; 2022; 13():973543. PubMed ID: 36203612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
    Lorenzini T; Fliegauf M; Klammer N; Frede N; Proietti M; Bulashevska A; Camacho-Ordonez N; Varjosalo M; Kinnunen M; de Vries E; van der Meer JWM; Ameratunga R; Roifman CM; Schejter YD; Kobbe R; Hautala T; Atschekzei F; Schmidt RE; Schröder C; Stepensky P; Shadur B; Pedroza LA; van der Flier M; Martínez-Gallo M; Gonzalez-Granado LI; Allende LM; Shcherbina A; Kuzmenko N; Zakharova V; Neves JF; Svec P; Fischer U; Ip W; Bartsch O; Barış S; Klein C; Geha R; Chou J; Alosaimi M; Weintraub L; Boztug K; Hirschmugl T; Dos Santos Vilela MM; Holzinger D; Seidl M; Lougaris V; Plebani A; Alsina L; Piquer-Gibert M; Deyà-Martínez A; Slade CA; Aghamohammadi A; Abolhassani H; Hammarström L; Kuismin O; Helminen M; Allen HL; Thaventhiran JE; Freeman AF; Cook M; Bakhtiar S; Christiansen M; Cunningham-Rundles C; Patel NC; Rae W; Niehues T; Brauer N; Syrjänen J; Seppänen MRJ; Burns SO; Tuijnenburg P; Kuijpers TW; ; Warnatz K; Grimbacher B;
    J Allergy Clin Immunol; 2020 Oct; 146(4):901-911. PubMed ID: 32278790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.
    Tuovinen EA; Kuismin O; Soikkonen L; Martelius T; Kaustio M; Hämäläinen S; Viskari H; Syrjänen J; Wartiovaara-Kautto U; Eklund KK; Saarela J; Varjosalo M; Kere J; Hautala T; Seppänen MRJ
    Clin Immunol; 2023 Jan; 246():109181. PubMed ID: 36356849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature.
    Ricci S; Abu-Rumeileh S; Campagna N; Barbati F; Stagi S; Canessa C; Lodi L; Palterer B; Maggi L; Matucci A; Vultaggio A; Annunziato F; Azzari C
    Front Immunol; 2023; 14():1224603. PubMed ID: 37600787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID.
    Liu A; Liu Q; Leng S; Zhang X; Feng Q; Peng J; Feng G
    Clin Exp Immunol; 2023 Mar; 211(1):68-77. PubMed ID: 36571238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunodeficiency caused by a novel homozygous NFKB1 mutation.
    Mandola AB; Sharfe N; Nagdi Z; Dadi H; Vong L; Merico D; Ngan B; Reid B; Roifman CM
    J Allergy Clin Immunol; 2021 Feb; 147(2):727-733.e2. PubMed ID: 32980423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of
    Somma D; Kok FO; Kerrigan D; Wells CA; Carmody RJ
    Front Immunol; 2021; 12():669906. PubMed ID: 34721373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-Onset Antibody Deficiency Due to Monoallelic Alterations in
    Schröder C; Sogkas G; Fliegauf M; Dörk T; Liu D; Hanitsch LG; Steiner S; Scheibenbogen C; Jacobs R; Grimbacher B; Schmidt RE; Atschekzei F
    Front Immunol; 2019; 10():2618. PubMed ID: 31803180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders.
    Ameratunga R; Ahn Y; Jordan A; Lehnert K; Brothers S; Woon ST
    Expert Rev Clin Immunol; 2018 Jul; 14(7):549-556. PubMed ID: 29806948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFKB1: a suppressor of inflammation, ageing and cancer.
    Cartwright T; Perkins ND; L Wilson C
    FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
    Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
    Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hypermorphic variants in IRF2BP2 identified in patients with common variable immunodeficiency and autoimmunity.
    Anim M; Sogkas G; Camacho-Ordonez N; Schmidt G; Elsayed A; Proietti M; Witte T; Grimbacher B; Atschekzei F
    Clin Immunol; 2024 Sep; 266():110326. PubMed ID: 39059757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.